---
schema_version: "secwatch.filing_event.v1"
accession: "0001387131-23-006116"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2023-05-05T23:59:59+00:00"
generated_at: "2026-06-15T16:24:00.929957+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tonix shareholders elect eight directors, ratify auditor, and approve employee stock purchase plan at annual meeting

## Summary
- Elected Seth Lederman, Richard Bagger, Margaret Smith Bell, David Grange, Adeoye Olukotun, Newcomb Stillwell, Carolyn Taylor, James Treco each with >7.7M votes for; 16.02M broker non-votes each.
- Ratified EisnerAmper LLP as auditor for FY2023: 23.37M for, 590,326 against, 567,644 abstain.
- Approved 2023 Employee Stock Purchase Plan: 7.25M for, 941,906 against, 308,826 abstain, plus 16.02M broker non-votes.
- Shareholder turnout: 24.52M shares (39.14% of outstanding) represented at meeting.

## SEC filing metadata
- accession: 0001387131-23-006116
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2023-05-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000138713123006116/0001387131-23-006116-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000138713123006116/tnxp-8k_050523.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001387131-23-006116
- JSON: https://secwatch.observer/filing/0001387131-23-006116.json
- Plain text: https://secwatch.observer/filing/0001387131-23-006116.txt

## Key facts
- Shareholder Votes
  Tonix Pharmaceuticals Holding Corp. shareholders approved Ratification of EisnerAmper LLP as independent registered public accounting firm for fiscal year 2023 at the 2023-05-05 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-05
  source text: Proposal 2 The Company’s shareholders ratified the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, as set forth below: Votes For Votes Against Abstentions Broker Non-Votes 23,366,768 590,326 567,644 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000138713123006116/0001387131-23-006116-index.htm
- Shareholder Votes
  Tonix Pharmaceuticals Holding Corp. shareholders approved Election of eight individuals to the Board of Directors at the 2023-05-05 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-05
  source text: Proposal 1 The Company’s shareholders elected eight individuals to the Board of Directors as set forth below: Name Votes For Votes Withheld Broker Non-Votes Seth Lederman 7,724,861 776,948 16,022,826 Richard Bagger 7,818,813 683,001 16,022,826 Margaret Smith Bell 7,867,431 634,381 16,022,826 David Grange 7,865,997 635,815 16,022,826 Adeoye Olukotun 7,832,903 668,909 16,022,826 Newcomb Stillwell 7,860,358 641,455 16,022,826 Carolyn Taylor 7,873,125 628,687 16,022,826 James Treco 7,866,358 635,454 16,022,826
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000138713123006116/0001387131-23-006116-index.htm
- Shareholder Votes
  Tonix Pharmaceuticals Holding Corp. shareholders approved Approval of Tonix Pharmaceuticals Holding Corp. 2023 Employee Stock Purchase Plan at the 2023-05-05 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-05-05
  source text: Proposal 3 The Company’s shareholders approved the Tonix Pharmaceuticals Holding Corp. 2023 Employee Stock Purchase Plan as set forth below: Votes For Votes Against Abstentions Broker Non-Votes 7,251,180 941,906 308,826 16,022,826
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000138713123006116/0001387131-23-006116-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.